Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

Sylvester Comprehensive Cancer Center at the University of Miami

1475 NW 12th Ave, 1st Floor, Miami, FL 33136

Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the University of Miami Miller School of Medicine, is the only cancer center in South Florida designated by the National Cancer Institute. NCI designation recognizes that Sylvester has met the most rigorous standards for cancer research beginning in our laboratories, extending to patient care, and meeting specific needs in our community. As a result, Sylvester is among an elite group of only 71 centers across the country to have earned this recognition. Sylvester is known as South Florida’s leader in patient-focused cancer research and care, offering the only Phase 1 clinical trials program – the first step in evaluating how patients respond to the latest investigational treatments. NCI designation further expands Sylvester’s ability to provide access to novel therapies through more clinical trials and collaboration with other designated centers. Equipped with a highly qualified team of more than 300 cancer-focused physicians and researchers working together, Sylvester discovers, develops and delivers more precision cancer care. To serve current and future patients, Sylvester has a network of conveniently located outpatient treatment facilities throughout South Florida.

Website: sylvester.org

Contact:
Sylvester Clinical Trials Hotline:
305-243-2647

Trials at this location:

HCRN BRE12-158

A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer.

Status: Closed to Accrual
Read More

HCRN GI16-288

A Phase II Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Resectable Hepatic-Limited Metastatic Colorectal Cancer HCRN: GI16-288

Status: Closed to Accrual
Read More